Carregant...
Risk of hypertension in cancer patients treated with abiraterone: a meta-analysis
BACKGROUND: Hypertension is one of the major side effects associated with abiraterone in the treatment of advanced prostate cancer. The specific contribution of abiraterone to hypertension has not been defined. We performed a systematic review and meta-analysis of randomized clinical trials to deter...
Guardat en:
| Publicat a: | Clin Hypertens |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6545007/ https://ncbi.nlm.nih.gov/pubmed/31168403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40885-019-0116-x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|